Eli Lilly and Company & Nubank
3 shared events · Importance 3 · Last updated Jun 26, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Business
Eli Lilly and Company: Eli Lilly and Company>>> advanced after positive trial results for its next-generation obesity drug, retatrutide, which showed benefits beyond weight loss.
Nubank: Nubank' stock declined after China's China — State Administration for Market Regulation summoned leading e-commerce companies over misleading promotions.
May 20, 2026 · 72 articles
Business
Eli Lilly and Company: Eli Lilly and Company is a recipient of the 2026 Visionary Growth Leadership Best Practices Recognition, which could positively influence its brand image and investor perception.
Nubank: ARM Holdings is a recipient of the 2026 Visionary Growth Leadership Best Practices Recognition, which could positively influence its brand image and investor perception.
Jun 15, 2026 · 6 articles
Business
Eli Lilly and Company: Eli Lilly and Company is mentioned as one of the companies that SpaceX's valuation will surpass, emphasizing the magnitude of SpaceX's market entry.
Nubank: Nubank' 2023 debut is mentioned as a recent large IPO for which Nasdaq-100 conducted test runs, providing context for the current preparations for SpaceX.
Mar 09, 2018 · 538 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how Eli Lilly and Company and Nubank interact across events, view sentiment trends, and discover connected entities.
Open Dashboard